Physician

Agatha Yvonne Obertynski, M.D.

According to 2025 Medicare claims, Agatha Obertynski, M.D. (NPI: 1902099310) practices ophthalmology in the Warren-Troy-Farmington Hills, MI market, with the plurality of this provider's patient population coming from Macomb, MI. This provider's primary affiliated billing organization is UNIVERSITY EYE CARE, PC (NPI: 1972680577; TIN: 510435671) and primary practice location at 48314-1038.

Obertynski's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 576 traditional Medicare patients, billed 1,376 HCPCS/CPT codes, and received $85,256 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 752 prescription claims across 262 beneficiaries totaling $166,791 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 1 records totaling $20. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $30,657 to $166,791. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$43K$87K2015 Medicare payment: $80,278 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $71,155 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $76,725 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $75,427 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $86,771 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $68,064 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $76,317 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $83,012 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $81,512 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $85,256 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20153601,006$80,278
20163781,330$71,155
20174351,385$76,725
20184271,347$75,427
20194861,475$86,771
20203871,002$68,064
20214551,222$76,317
20224711,236$83,012
20235001,352$81,512
20245761,376$85,256

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$83K$167K2015 Drug cost: $30,657 (USD; Tot_Drug_Cst)2016 Drug cost: $37,893 (USD; Tot_Drug_Cst)2017 Drug cost: $48,745 (USD; Tot_Drug_Cst)2018 Drug cost: $61,223 (USD; Tot_Drug_Cst)2019 Drug cost: $50,386 (USD; Tot_Drug_Cst)2020 Drug cost: $58,168 (USD; Tot_Drug_Cst)2021 Drug cost: $85,861 (USD; Tot_Drug_Cst)2022 Drug cost: $81,718 (USD; Tot_Drug_Cst)2023 Drug cost: $124,372 (USD; Tot_Drug_Cst)2024 Drug cost: $166,791 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015116434$30,657
2016104396$37,893
2017113462$48,745
2018120535$61,223
2019122465$50,386
2020135475$58,168
2021166527$85,861
2022162526$81,718
2023225684$124,372
2024262752$166,791

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system350354$84
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more124188$62
92012Established patient problem focused exam of visual system101118$61
92083Exam of visual field with extended testing120129$45
92133Imaging of optic nerve104105$25

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine463,345$67,584
CyclosporineCyclosporine453,362$23,200
MieboPerfluorohexyloctane/Pf20600$14,817
LumiganBimatoprost161,160$10,381
CombiganBrimonidine Tartrate/Timolol211,190$9,405

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$20Alcon Vision LLC
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Agatha Yvonne Obertynski, M.D.?

Tedicare shows public-source Medicare data for Agatha Yvonne Obertynski, M.D. (NPI 1902099310), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Agatha Yvonne Obertynski, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Agatha Yvonne Obertynski, M.D.?

Agatha Yvonne Obertynski, M.D. is linked to UNIVERSITY EYE CARE, PC (billing NPI 1972680577) in the available physician profile data.

Does Agatha Yvonne Obertynski, M.D. have Open Payments data?

Agatha Yvonne Obertynski, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.